🕵️ Mangoceuticals, Inc. ($MGRX)
SEC insider & ownership activity, last 12 months · CIK 1938046 · every row links its SEC filing
Insider sell value was withheld pending verification over the last 12 months. Jacob D. Cohen added 11.0% → 14.6%; The Tiger CUB Trust trimmed 7.3% → 6.8%. One red-flag 8-K in the window: Delisting notice (3.01), Feb 4, 2026.
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, value withheld pending verification (4 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Eugene M. Johnston | 0 | – | 3 | $21K | Dec 15, 2025 |
| Alex P. Hamilton | 0 | – | 1 | value withheld pending verification | Nov 19, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Jacob D. Cohen | 14.6% | 13D | Jul 21, 2025 | filing ↗ | |
| Greenfield Investments, Ltd | 14.4% | 13G | Jan 22, 2025 | filing ↗ | |
| Peter M. Karam | 14.4% | 13G | Jan 22, 2025 | filing ↗ | |
| The Tiger CUB Trust | 6.8% | 13D | Jul 21, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Eugene M. Johnston | $149K | Dec 3, 2025 | filing ↗ |
| Alex P. Hamilton | $155K | Nov 19, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Agreement terminated (1.02) | Aug 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 19, 2026 | filing ↗ |
| Other events (8.01) | Aug 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 4, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 28, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 28, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jul 28, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 28, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 29, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 29, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 16, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 16, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 23, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 19, 2026 | filing ↗ |
| Delisting notice (3.01) | Feb 4, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 18, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Dec 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 18, 2025 | filing ↗ |
| Material agreement (1.01) | Dec 17, 2025 | filing ↗ |
| Other events (8.01) | Dec 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 17, 2025 | filing ↗ |
| Material agreement (1.01) | Dec 4, 2025 | filing ↗ |
| New financial obligation (2.03) | Dec 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 4, 2025 | filing ↗ |
| Other events (8.01) | Nov 13, 2025 | filing ↗ |